Funding to support Phase 3 trial of denovoSkin™ and preparation for its commercialization, to advance the automation platform for tissue bioengineering, and to enable the market launch of VitiCell®.

Survivors of Switzerland’s devastating Crans-Montana fire disaster who suffered severe burns are being treated with advanced lab-grown skin grafts, developed using their own cells to improve healing ...

Burn, trauma, and plastic surgery patients and others needing skin autografts often have limited quantities of healthy tissue from which to take skin biopsies, and when skin grafts are transplanted, ...

Co-founder and CEO of CUTISS, Daniela Marino, PhD, talks about her switch from academia to the biotech industry and her 16-year journey developing a first-in-class personalized tissue therapy. In this ...

Funding to support Phase 3 trial of denovoSkin and preparation for its commercialization, to advance the automation platform for tissue bioengineering, and to enable the market launch of VitiCell®.